Citation Impact
Citing Papers
A Recombinant Modified Vaccinia Ankara Vaccine Encoding Epstein–Barr Virus (EBV) Target Antigens: A Phase I Trial in UK Patients with EBV-Positive Cancer
2014
Improved cellular and humoral immune responses in vivo following targeting of HIV Gag to dendritic cells within human anti–human DEC205 monoclonal antibody
2010 StandoutNobel
Durable Complete Responses in Heavily Pretreated Patients with Metastatic Melanoma Using T-Cell Transfer Immunotherapy
2011 Standout
Phase I Trial of Recombinant Modified Vaccinia Ankara Encoding Epstein–Barr Viral Tumor Antigens in Nasopharyngeal Carcinoma Patients
2013
Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance
2018 Standout
Impact assessment of non-pharmaceutical interventions against coronavirus disease 2019 and influenza in Hong Kong: an observational study
2020
TT Virus Infection Does Not Affect the Clinical Profiles of Patients with Hepatitis B and C in Yanbian City, China
2003
A phase II study evaluating the safety and efficacy of an adenovirus-ΔLMP1-LMP2 transduced dendritic cell vaccine in patients with advanced metastatic nasopharyngeal carcinoma
2011
Association of SLC11A1 (NRAMP1) polymorphisms with pulmonary Mycobacterium avium complex infection
2012
Frequent detection of the replicative form of TT virus DNA in peripheral blood mononuclear cells and bone marrow cells in cancer patients
2002
Visceral leishmaniasis: what are the needs for diagnosis, treatment and control?
2007 Standout
Nutritional immunity: transition metals at the pathogen–host interface
2012 Standout
TT Viruses: Oncogenic or Tumor-Suppressive Properties?
2008 StandoutNobel
Pathogenesis and therapy of psoriasis
2007 StandoutNature
Exosomes: Extracellular organelles important in intercellular communication
2010 Standout
Hyperimmune IV Immunoglobulin Treatment
2013
Regulatory assessment of chemical mixtures: Requirements, current approaches and future perspectives
2016 Standout
Clustering and superspreading potential of SARS-CoV-2 infections in Hong Kong
2020 Standout
British Thoracic Society guidelines for the management of non-tuberculous mycobacterial pulmonary disease (NTM-PD)
2017 Standout
Nowcasting and forecasting the potential domestic and international spread of the 2019-nCoV outbreak originating in Wuhan, China: a modelling study
2020 Standout
Membrane vesicles as conveyors of immune responses
2009 Standout
PulmonaryMycobacterium aviumcomplex infection: association withNRAMP1polymorphisms
2007
The cytokine storm of severe influenza and development of immunomodulatory therapy
2015 Standout
Nasopharyngeal carcinoma
2015 Standout
Exosomes released by EBV-infected nasopharyngeal carcinoma cells convey the viral Latent Membrane Protein 1 and the immunomodulatory protein galectin 9
2006
Real-time numerical forecast of global epidemic spreading: case study of 2009 A/H1N1pdm
2012
Economic Evaluation of Individual School Closure Strategies: The Hong Kong 2009 H1N1 Pandemic
2016
Regulation of immune responses by extracellular vesicles
2014 Standout
School closure and management practices during coronavirus outbreaks including COVID-19: a rapid systematic review
2020 Standout
Brominated flame retardants – Exposure and risk assessment for the general population
2015
Factors associated with uptake of vaccination against pandemic influenza: A systematic review
2011
Spatiotemporal Dynamics of Intratumoral Immune Cells Reveal the Immune Landscape in Human Cancer
2013 Standout
Genetics and visceral leishmaniasis in the Sudan: seeking a link
2004
Immune escape by Epstein–Barr virus associated malignancies
2008
Case Fatality Risk of Influenza A (H1N1pdm09)
2013
Traditional Chinese Medicine in the Treatment of Patients Infected with 2019-New Coronavirus (SARS-CoV-2): A Review and Perspective
2020 Standout
TTV, a new human virus with single stranded circular DNA genome
2002
Vaccine hesitancy
2013 Standout
The Human Cancer Antigen Mesothelin Is More Efficiently Presented to the Mouse Immune System when Targeted to the DEC‐205/CD205 Receptor on Dendritic Cells
2009 StandoutNobel
Development of Virus-Like Particle Technology from Small Highly Symmetric to Large Complex Virus-Like Particle Structures
2013 Standout
SARS-CoV-2 in wastewater: State of the knowledge and research needs
2020 Standout
Extracellular vesicles: Exosomes, microvesicles, and friends
2013 Standout
Cell Therapy of Stage IV Nasopharyngeal Carcinoma With Autologous Epstein-Barr Virus–Targeted Cytotoxic T Lymphocytes
2005
Sexually Transmitted Infections Treatment Guidelines, 2021
2021 Standout
A global approach to tumor immunology.
2004
Routes and mechanisms of extracellular vesicle uptake
2014 Standout
Personnel scheduling: A literature review
2012 Standout
Immunology of Psoriasis
2014 Standout
Improving the evidence base for decision making during a pandemic: the example of 2009 influenza A/H1N1.
2011
Advances in leishmaniasis
2005 Standout
Prevention of Hepatitis B Virus Infection in the United States: Recommendations of the Advisory Committee on Immunization Practices
2018
Treatment of nasopharyngeal carcinoma with Epstein-Barr virus–specific T lymphocytes
2004
Epidemic processes in complex networks
2015 Standout
Priming of protective T cell responses against virus-induced tumors in mice with human immune system components
2009 StandoutNobel
Targeting the nuclear antigen 1 of Epstein-Barr virus to the human endocytic receptor DEC-205 stimulates protective T-cell responses
2008 StandoutNobel
Blood diffusion and Th1-suppressive effects of galectin-9–containing exosomes released by Epstein-Barr virus–infected nasopharyngeal carcinoma cells
2008
THE GENETICS OF PSORIASIS AND AUTOIMMUNITY
2005
Isolation of Multiple TT Virus Genotypes from Spleen Biopsy Tissue from a Hodgkin's Disease Patient: Genome Reorganization and Diversity in the Hypervariable Region
2004 StandoutNobel
Cellular Responses to Viral Infection in Humans: Lessons from Epstein-Barr Virus
2007
Supply chain management of blood products: A literature review
2011
Works of Che Kit Lin being referenced
Frequency of Epstein‐Barr virus‐specific cytotoxic T lymphocytes in the blood of Southern Chinese blood donors and nasopharyngeal carcinoma patients
2002
Extent and distribution of linkage disequilibrium around the SLC11A1 locus
2003
CD4 and CD8 T cell responses to tumour-associated Epstein–Barr virus antigens in nasopharyngeal carcinoma patients
2007
Estimating Infection Attack Rates and Severity in Real Time during an Influenza Pandemic: Analysis of Serial Cross-Sectional Serologic Surveillance Data
2011
Quantitative and genotypic analysis of TT virusinfection in Chinese blood donors
2001
Practical limitations of convalescent plasma collection: a case scenario in pandemic preparation for influenza A (H1N1) infection
2010
The Infection Attack Rate and Severity of 2009 Pandemic H1N1 Influenza in Hong Kong
2010
Predicting potential drop‐out and future commitment for first‐time donors based on first 1·5‐year donation patterns: the case in Hong Kong Chinese donors
2007
Inferring Influenza Infection Attack Rate from Seroprevalence Data
2014
Halogenated POPs and PAHs in Blood Plasma of Hong Kong Residents
2011
Occult hepatitis B infection in blood donors from South East Asia: molecular characterisation and potential mechanisms of occurrence
2012
CD4+T-Cell Responses to Epstein-Barr Virus Nuclear Antigen EBNA1 in Chinese Populations Are Highly Focused on Novel C-Terminal Domain-Derived Epitopes
2006
A serial cross-sectional serologic survey of 2009 Pandemic (H1N1) in Hong Kong: implications for future pandemic influenza surveillance.
2011